"Cysteamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A mercaptoethylamine compound that is endogenously derived from the COENZYME A degradative pathway. The fact that cysteamine is readily transported into LYSOSOMES where it reacts with CYSTINE to form cysteine-cysteamine disulfide and CYSTEINE has led to its use in CYSTINE DEPLETING AGENTS for the treatment of CYSTINOSIS.
Descriptor ID |
D003543
|
MeSH Number(s) |
D02.092.471.562.369 D02.886.489.472.369
|
Concept/Terms |
Cysteamine- Cysteamine
- beta-Mercaptoethylamine
- beta Mercaptoethylamine
- Mercaptoethylamine
- Mercamine
- Mercaptamine
- 2-Aminoethanethiol
- 2 Aminoethanethiol
- Cysteinamine
Cysteamine Bitartrate- Cysteamine Bitartrate
- Bitartrate, Cysteamine
- Cysteamine Tartrate (1:1)
- Cysteamine Tartrate
- Tartrate, Cysteamine
|
Below are MeSH descriptors whose meaning is more general than "Cysteamine".
Below are MeSH descriptors whose meaning is more specific than "Cysteamine".
This graph shows the total number of publications written about "Cysteamine" by people in this website by year, and whether "Cysteamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 0 | 3 | 3 |
2012 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
2020 | 0 | 1 | 1 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cysteamine" by people in Profiles.
-
Newborn Screening: Review of its Impact for Cystinosis. Cells. 2022 03 25; 11(7).
-
Ruptured gallbladder in cystinosis renal transplant recipient. Kidney Int. 2020 06; 97(6):1304.
-
Management of bone disease in cystinosis: Statement from an international conference. J Inherit Metab Dis. 2019 09; 42(5):1019-1029.
-
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease. Hum Mol Genet. 2019 06 01; 28(11):1837-1852.
-
Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease. Hepatology. 2018 03; 67(3):858-872.
-
Synergistic Cysteamine Delivery Nanowafer as an Efficacious Treatment Modality for Corneal Cystinosis. Mol Pharm. 2016 10 03; 13(10):3468-3477.
-
Quality of life is improved and kidney function preserved in patients with nephropathic cystinosis treated for 2 years with delayed-release cysteamine bitartrate. J Pediatr. 2014 Sep; 165(3):528-33.e1.
-
A gold nanoparticle platform for the delivery of functional microRNAs into cancer cells. Biomaterials. 2013 Jan; 34(3):807-16.
-
Luminescent gold nanoparticles with pH-dependent membrane adsorption. J Am Chem Soc. 2011 Jul 27; 133(29):11014-7.
-
Threonine metabolism in isolated rat hepatocytes. Am J Physiol Endocrinol Metab. 2001 Dec; 281(6):E1300-7.